Compare BLDR & TECH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLDR | TECH |
|---|---|---|
| Founded | 1998 | 1976 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | RETAIL: Building Materials | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.0B | 9.1B |
| IPO Year | 2005 | 1995 |
| Metric | BLDR | TECH |
|---|---|---|
| Price | $85.36 | $70.77 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 18 | 11 |
| Target Price | ★ $121.76 | $71.82 |
| AVG Volume (30 Days) | 2.3M | ★ 6.7M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.62% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.81 |
| Revenue | ★ $15,190,638,000.00 | $1,219,635,000.00 |
| Revenue This Year | $0.71 | $2.49 |
| Revenue Next Year | $4.52 | $6.40 |
| P/E Ratio | ★ N/A | $87.62 |
| Revenue Growth | N/A | ★ 5.23 |
| 52 Week Low | $65.10 | $43.20 |
| 52 Week High | $151.03 | $72.16 |
| Indicator | BLDR | TECH |
|---|---|---|
| Relative Strength Index (RSI) | 57.11 | 77.45 |
| Support Level | $74.63 | $56.38 |
| Resistance Level | $94.97 | $71.04 |
| Average True Range (ATR) | 4.25 | 1.67 |
| MACD | 1.21 | 1.69 |
| Stochastic Oscillator | 68.47 | 98.18 |
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. It reports in two segments: protein sciences (about 75% of revenue) and diagnostics and genomics (25%). The protein sciences segment sells reagents and analytical instruments used in life sciences research, including antibodies used in protein analysis. The diagnostics and genomics segment sells diagnostic reagents, molecular diagnostics, and spatial biology products. The United States accounts for about 55% of revenue. The firm also has operations in Europe, the Middle East, and Africa (20% of sales), the UK (5%), and Asia-Pacific (15%), with the rest of the world accounting for the remaining 5%.